Format

Send to

Choose Destination
See comment in PubMed Commons below
Neuropsychopharmacology. 2003 May;28(5):956-60. Epub 2003 Mar 19.

Association of a critical CSF tryptophan threshold level with depressive relapse.

Author information

1
Department of Psychiatry, Vanderbilt University School of Medicine, 1500 21st Avenue South, VAV 2200, Nashville, TN 37212, USA. ron.salomon@vanderbilt.edu

Abstract

This work studies association between relapse during acute tryptophan depletion (ATD) and CSF level of tryptophan (TRP) in remitted depressives treated with sertraline or bupropion. Eight medication-responding depressives ingested an ATD amino acid mixture during 48-h continuous CSF sampling before and after treatment. Mood rating scores were compared with nadir levels of TRP in CSF. CSF TRP nadirs averaged 8.7% of am baselines in remitted patients. Mood relapsed whenever the CSF nadir was below 40 nmol/l TRP in remitted patients, and never when above (Fisher's exact test, P=0.029). Relapsing medication responders also showed very low preantidepressant ATD-induced nadirs. ATD-induced relapses were associated with low CSF TRP levels. Individual susceptibility to depletion may be independent of antidepressant treatment, mood state, or treatment status. Resistance to relapse may invoke an undefined, protective CNS mechanism against extremely low CSF levels of TRP during ATD.

PMID:
12736634
DOI:
10.1038/sj.npp.1300098
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center